EI
BIIB icon

Ethic Inc’s Biogen BIIB Stock Holding History

Ethic Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Buy
50,034
+2,741
+6% +$524K 0.13% 140
2026
Q1 		$8.67M Sell
47,293
-1,298
-3% -$239K 0.14% 155
2025
Q4 		$8.55M Buy
48,591
+4,095
+9% +$669K 0.13% 152
2025
Q3 		$6.23M Buy
44,496
+32,058
+258% +$4.33M 0.1% 198
2025
Q2 		$1.57M Buy
12,438
+4,583
+58% +$571K 0.03% 498
2025
Q1 		$1.04M Sell
7,855
-7,057
-47% -$1.01M 0.02% 590
2024
Q4 		$2.28M Buy
14,912
+7,743
+108% +$1.31M 0.05% 388
2024
Q3 		$1.55M Sell
7,169
-691
-9% -$145K 0.04% 457
2024
Q2 		$1.82M Buy
7,860
+691
+10% +$150K 0.04% 409
2024
Q1 		$1.55M Sell
7,169
-6,690
-48% -$1.57M 0.04% 458
2023
Q4 		$3.59M Buy
13,859
+6,290
+83% +$1.54M 0.11% 225
2023
Q3 		$1.95M Buy
7,569
+1,729
+30% +$462K 0.07% 323
2023
Q2 		$1.66M Sell
5,840
-517
-8% -$154K 0.06% 346
2023
Q1 		$1.77M Sell
6,357
-2,894
-31% -$801K 0.07% 315
2022
Q4 		$2.56M Buy
9,251
+4,048
+78% +$1.14M 0.14% 192
2022
Q3 		$1.39M Buy
5,203
+1,681
+48% +$357K 0.09% 268
2022
Q2 		$718K Buy
3,522
+1,025
+41% +$210K 0.05% 389
2022
Q1 		$526K Buy
2,497
+327
+15% +$71.1K 0.04% 451
2021
Q4 		$521K Sell
2,170
-776
-26% -$200K 0.04% 400
2021
Q3 		$834K Buy
2,946
+747
+34% +$245K 0.09% 260
2021
Q2 		$761K Sell
2,199
-170
-7% -$51.5K 0.09% 260
2021
Q1 		$663K Buy
2,369
+515
+28% +$139K 0.12% 224
2020
Q4 		$454K Buy
1,854
+857
+86% +$221K 0.12% 229
2020
Q3 		$283K Sell
997
-752
-43% -$210K 0.11% 234
2020
Q2 		$468K Sell
1,749
-111
-6% -$33.4K 0.27% 109
2020
Q1 		$588K Buy
1,860
+162
+10% +$49.2K 0.49% 58
2019
Q4 		$504K Buy
+1,698
New +$471K 0.37% 88

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Ethic Inc's BIIB Position: Q2 2026 in Review

Ethic Inc increased its Biogen (BIIB) stake by 5.8% in Q2 2026, buying an estimated $524K and bringing the position to 50,034 shares worth $10.8M. The position accounts for 0.13% of the portfolio, ranked #140.

Ethic Inc first reported a position in BIIB in Q4 2019 and has held it in 27 quarters since. 362 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Ethic Inc held 50,034 shares of Biogen worth $10.8M as of Q2 2026.
  • Ethic Inc bought 2,741 Biogen shares in Q2 2026, an estimated $524K.
  • Biogen made up 0.13% of Ethic Inc's portfolio in Q2 2026, its #140 holding.
  • Ethic Inc first reported a position in Biogen in Q4 2019 and has held it in 27 quarters since.
  • 362 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.